Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Other Operating Expenses (2018 - 2023)

Exagen's Other Operating Expenses history spans 6 years, with the latest figure at -$17.5 million for Q4 2023.

  • For Q4 2023, Other Operating Expenses fell 247.88% year-over-year to -$17.5 million; the TTM value through Sep 2024 reached -$17.5 million, down 159.66%, while the annual FY2022 figure was $29.7 million, 44.36% up from the prior year.
  • Other Operating Expenses reached -$17.5 million in Q4 2023 per XGN's latest filing, down from $5.7 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $11.8 million in Q4 2022 to a low of -$17.5 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $4.3 million, with a median of $5.0 million recorded in 2019.
  • Peak YoY movement for Other Operating Expenses: surged 139.22% in 2022, then plummeted 247.88% in 2023.
  • A 5-year view of Other Operating Expenses shows it stood at $4.6 million in 2019, then fell by 5.58% to $4.3 million in 2020, then rose by 13.93% to $4.9 million in 2021, then skyrocketed by 139.22% to $11.8 million in 2022, then tumbled by 247.88% to -$17.5 million in 2023.
  • Per Business Quant, the three most recent readings for XGN's Other Operating Expenses are -$17.5 million (Q4 2023), $5.7 million (Q3 2023), and $5.8 million (Q2 2023).